Movement Alert｜10x Genomics, Inc. Intraday Rise 5.01% in Regular Trading, earnings beat and raised revenue outlook draw funds back

Market Focus11-09

On November 9, 10x Genomics, Inc. rose 5.01% in Regular Trading, trading at $62.24 per share, with turnover of $7.9993 million.

The move followed a renewed market focus on the company’s latest quarterly results, which showed a loss of $0.15 per share, better than the expected loss of $0.25, and revenue of $150.667 million, above the expected $147.859 million.

The company also raised its full-year revenue guidance to $625 million-$635 million from $610 million-$630 million, above the consensus estimate of $620.8 million. Recent trading around the earnings release was volatile, with shares initially under pressure despite the beat, but the latest rebound suggests capital is re-engaging with the improved operating trend and higher revenue outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment